Literature DB >> 25803623

An inflammatory equine model demonstrates dynamic changes of immune response and cartilage matrix molecule degradation in vitro.

Emilia Svala1, Maria Löfgren, Carina Sihlbom, Ulla Rüetschi, Anders Lindahl, Stina Ekman, Eva Skiöldebrand.   

Abstract

The molecular aspects of inflammation were investigated in equine articular cartilage explants using quantitative proteomics. Articular cartilage explants were stimulated with interleukin (IL)-1β in vitro for 25 days, and proteins released into cell culture media were chemically labeled with isobaric mass tags and analyzed by liquid chromatography-tandem mass spectrometry. A total of 127 proteins were identified and quantified in media from explants. IL-1β-stimulation resulted in an abundance of proteins related to inflammation, including matrix metalloproteinases, acute phase proteins, complement components and IL-6. Extracellular matrix (ECM) molecules were released at different time points, and fragmentation of aggrecan and cartilage oligomeric matrix protein was observed at days 3 and 6, similar to early-stage OA in vivo. Degradation products of the collagenous network were observed at days 18 and 22, similar to late-stage OA. This model displays a longitudinal quantification of released molecules from the ECM of articular cartilage. Identification of dynamic changes of extracellular matrix molecules in the secretome of equine explants stimulated with IL-1β over time may be useful for identifying components released at different time points during the spontaneous OA process.

Entities:  

Keywords:  Horse; IL-1β; matrix molecules; osteoarthritis; proteomics

Mesh:

Substances:

Year:  2015        PMID: 25803623     DOI: 10.3109/03008207.2015.1027340

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  7 in total

1.  The miRNA-mRNA interactome of murine induced pluripotent stem cell-derived chondrocytes in response to inflammatory cytokines.

Authors:  Alison K Ross; Rodrigo Coutinho de Almeida; Yolande F M Ramos; Jiehan Li; Ingrid Meulenbelt; Farshid Guilak
Journal:  FASEB J       Date:  2020-08-07       Impact factor: 5.191

2.  Cartilage oligomeric matrix protein neoepitope in the synovial fluid of horses with acute lameness: A new biomarker for the early stages of osteoarthritis.

Authors:  E Skiöldebrand; S Ekman; L Mattsson Hultén; E Svala; K Björkman; A Lindahl; A Lundqvist; P Önnerfjord; C Sihlbom; U Rüetschi
Journal:  Equine Vet J       Date:  2017-02-28       Impact factor: 2.888

3.  Protective effects of baicalin on rabbit articular chondrocytes in vitro.

Authors:  Xianyuan Huang; Huayu Wu; Liqin Wang; Li Zheng; Jinmin Zhao
Journal:  Exp Ther Med       Date:  2017-02-10       Impact factor: 2.447

4.  Induction of Synovitis Using Interleukin-1 Beta: Are There Differences in the Response of Middle Carpal Joint Compared to the Tibiotarsal Joint?

Authors:  Aimee C Colbath; Steven W Dow; Leone S Hopkins; Jennifer N Phillips; C Wayne McIlwraith; Laurie R Goodrich
Journal:  Front Vet Sci       Date:  2018-08-31

5.  Effect of circadian rhythm, age, training and acute lameness on serum concentrations of cartilage oligomeric matrix protein (COMP) neo-epitope in horses.

Authors:  S Ekman; A Lindahl; U Rüetschi; A Jansson; K Björkman; K Abrahamsson-Aurell; S Björnsdóttir; M Löfgren; L Mattsson Hultén; E Skiöldebrand
Journal:  Equine Vet J       Date:  2019-03-06       Impact factor: 2.888

6.  Ex Vivo Equine Cartilage Explant Osteoarthritis Model: A Metabolomics and Proteomics Study.

Authors:  James R Anderson; Marie M Phelan; Laura Foddy; Peter D Clegg; Mandy J Peffers
Journal:  J Proteome Res       Date:  2020-08-06       Impact factor: 4.466

7.  COMP (Cartilage Oligomeric Matrix Protein) Neoepitope: A Novel Biomarker to Identify Symptomatic Carotid Stenosis.

Authors:  Joakim Sandstedt; Karin Vargmar; Kristina Björkman; Ulla Ruetschi; Göran Bergström; Lillemor Mattsson Hultén; Eva Skiöldebrand
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-01-21       Impact factor: 8.311

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.